The HinduLean L·
Merck drug extends survival in endometrial cancer trial, wins U.S. priority review
The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
Read at The Hindu →
Science · 2 sources covering this
Merck drug extends survival in endometrial cancer trial, wins U.S. priority review
The drug delivers a cancer-killing payload to cells that carry a protein common in endometrial tumours
Coverage spectrum
2 L · 0 C · 0 R
How 2 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/4091511017bf8ad8bf979215317ca5d7a6b01cc7" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Merck drug extends survival in endometrial cancer trial, wins U.S. priority review"></iframe>
